Drug supply for patients with epilepsy under the program of state guarantees in the Kyrgyz Republic

The article presents the results of the analysis of drug provision for patients with epilepsy in Kyrgyzstan under the preferential program of state guarantees within the framework of compulsory medical insurance. The purpose of the study: analysis of preferential drug provision for patients diagnosed with epilepsy in the Kyrgyz Republic. Materials and research methods. Research materials: information data of the Compulsory Medical Insurance Fund under the Ministry of Health of the Kyrgyz Republic. Research methods: content analysis, graphical and statistical methods. Research results. As a result of the analysis of preferential drug provision for patients with epilepsy in the Kyrgyz Republic, data were obtained on assessing the availability of drug therapy for patients in this group. Patients diagnosed with epilepsy in 2022 received a total of 37,616 prescriptions for a reimbursement of about 16.8 million soms. When comparing data with 2021, the number of prescriptions issued to patients diagnosed with epilepsy in 2022 increased by 7485 prescriptions nationwide, and the amount of reimbursement increased by 12.7%. The main number of preferential prescriptions for the analyzed period was issued to the category of insured citizens, persons with disabilities, disabled people. The largest number of preferential prescriptions for patients diagnosed with epilepsy was issued in the southern region of the country - in Osh and Jalal-Abad regions.